{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:46:07Z","timestamp":1768437967567,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002973","name":"Daiichi Sankyo Company, Limited","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","thebonejournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.bone.2018.07.026","type":"journal-article","created":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T01:59:50Z","timestamp":1533175190000},"page":"172-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Siglec-15-targeting therapy increases bone mass in rats without impairing skeletal growth"],"prefix":"10.1016","volume":"116","author":[{"given":"Dai","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2436-2175","authenticated-orcid":false,"given":"Masahiko","family":"Takahata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Ota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chie","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eisuke","family":"Tsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiharu","family":"Hiruma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Hamano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeto","family":"Hiratsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Amizuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoka","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norimasa","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bone.2018.07.026_bb0005","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.beem.2008.06.001","article-title":"Epidemiology of osteoporosis","volume":"22","author":"Holroyd","year":"2008","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bone.2018.07.026_bb0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrrheum.2009.260","article-title":"Osteoporosis: impact on health and economics","volume":"6","author":"Harvey","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"issue":"7","key":"10.1016\/j.bone.2018.07.026_bb0015","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1359\/jbmr.090202","article-title":"Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemia: results of the Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) research program","volume":"24","author":"Halton","year":"2009","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bone.2018.07.026_bb0020","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s00223-001-0043-0","article-title":"Glucorticoids and bone: some general remarks and some special observations in pediatric patients","volume":"70","author":"Bianchi","year":"2002","journal-title":"Calcif. Tissue Int."},{"issue":"1","key":"10.1016\/j.bone.2018.07.026_bb0025","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/01.mpg.0000228105.91240.80","article-title":"Osteoporosis in pediatric patients suffering from chronic inflammatory bowel disease with and without steroid treatment","volume":"43","author":"Walther","year":"2006","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"10","key":"10.1016\/j.bone.2018.07.026_bb0030","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","article-title":"Glucocorticoid-induced osteoporosis: pathophysiology and therapy","volume":"18","author":"Canalis","year":"2007","journal-title":"Osteoporos. Int."},{"issue":"4","key":"10.1016\/j.bone.2018.07.026_bb0035","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.bone.2007.07.008","article-title":"Osteoporosis in children and adolescents","volume":"41","author":"Bianchi","year":"2007","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.bone.2018.07.026_bb0040","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/nrrheum.2009.259","article-title":"Management of glucocorticoid-induced osteoporosis","volume":"6","author":"Compston","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2","key":"10.1016\/j.bone.2018.07.026_bb0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jmg.16.2.101","article-title":"Genetic heterogeneity in osteogenesis imperfecta","volume":"16","author":"Sillence","year":"1979","journal-title":"J. Med. Genet."},{"issue":"9418","key":"10.1016\/j.bone.2018.07.026_bb0050","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","article-title":"Osteogenesis imperfecta","volume":"363","author":"Rauch","year":"2004","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.bone.2018.07.026_bb0055","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1053\/j.seminhematol.2013.06.007","article-title":"A 50-year journey to cure childhood acute lymphoblastic leukemia","volume":"50","author":"Pui","year":"2013","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.bone.2018.07.026_bb0060","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1196\/annals.1402.089","article-title":"Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy","volume":"1117","author":"Russell","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.bone.2018.07.026_bb0065","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1210\/jc.2008-1531","article-title":"Clinical review 1: bisphosphonate use in childhood osteoporosis","volume":"94","author":"Bachrach","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bone.2018.07.026_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005088.pub2","article-title":"Bisphosphonate therapy for osteogenesis imperfecta","author":"Phillipi","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bone.2018.07.026_bb0075","series-title":"Human Anatomy and Physiology","author":"Marieb","year":"2010"},{"issue":"4","key":"10.1016\/j.bone.2018.07.026_bb0080","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/jor.1100140410","article-title":"Cell cycle analysis of proliferative zone chondrocytes in growth plates elongating at different rates","volume":"14","author":"Wilsman","year":"1996","journal-title":"J. Orthop. Res."},{"issue":"14","key":"10.1016\/j.bone.2018.07.026_bb0085","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199810013391402","article-title":"Cyclic administration of pamidronate in children with severe osteogenesis imperfecta","volume":"339","author":"Glorieux","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.bone.2018.07.026_bb0090","first-page":"535","article-title":"Adenocarcinoma of the gastric cardia: prognostic significance of pathologic and treatment factors","volume":"94","author":"Tsai","year":"1995","journal-title":"J. Formos. Med. Assoc."},{"issue":"2","key":"10.1016\/j.bone.2018.07.026_bb0095","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00005650-199533020-00003","article-title":"Comparison of the Medical Outcomes Study Short-Form 36-Item Health Survey in black patients and white patients with acute chest pain","volume":"33","author":"Johnson","year":"1995","journal-title":"Med. Care"},{"issue":"1","key":"10.1016\/j.bone.2018.07.026_bb0100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bone.2012.11.036","article-title":"Impaired osteoclast differentiation and function and mild osteopetrosis development in Siglec-15-deficient mice","volume":"53","author":"Hiruma","year":"2013","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bone.2018.07.026_bb0105","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.bbrc.2011.05.015","article-title":"Siglec-15, a member of the sialic acid-binding lectin, is a novel regulator for osteoclast differentiation","volume":"409","author":"Hiruma","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"21","key":"10.1016\/j.bone.2018.07.026_bb0110","doi-asserted-by":"crossref","first-page":"17493","DOI":"10.1074\/jbc.M111.324194","article-title":"Siglec-15 protein regulates formation of functional osteoclasts in concert with DNAX-activating protein of 12\u202fkDa (DAP12)","volume":"287","author":"Ishida-Kitagawa","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"Pt 17","key":"10.1016\/j.bone.2018.07.026_bb0115","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1242\/jcs.069872","article-title":"Cytoskeletal dysfunction dominates in DAP12-deficient osteoclasts","volume":"123","author":"Zou","year":"2010","journal-title":"J. Cell Sci."},{"issue":"12","key":"10.1016\/j.bone.2018.07.026_bb0120","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1002\/jbmr.1989","article-title":"Siglec-15 regulates osteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase\/Akt and Erk pathways in association with signaling Adaptor DAP12","volume":"28","author":"Kameda","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2018.07.026_bb0125","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/jbmr.5650050312","article-title":"Aminohydroxybutane bisphosphonate inhibits bone loss due to immobilization in rats","volume":"5","author":"Thompson","year":"1990","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.bone.2018.07.026_bb0130","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/jbmr.5650060405","article-title":"The bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in rats","volume":"6","author":"Seedor","year":"1991","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2018.07.026_bb0135","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0022-3565(24)37566-4","article-title":"Effects of continuous alendronate treatment on bone mass and mechanical properties in ovariectomized rats: comparison with pamidronate and etidronate in growing rats","volume":"286","author":"Azuma","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"7","key":"10.1016\/j.bone.2018.07.026_bb0140","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1359\/jbmr.2003.18.7.1217","article-title":"Dietary calcium and phosphorus ratio regulates bone mineralization and turnover in vitamin D receptor knockout mice by affecting intestinal calcium and phosphorus absorption","volume":"18","author":"Masuyama","year":"2003","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2018.07.026_bb0145","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bone.2018.07.026_bb0150","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S8756-3282(99)00212-4","article-title":"Long-term therapy of ovariectomy-induced osteopenia with parathyroid hormone analog SDZ PTS 893 and bone maintenance in retired breeder rats","volume":"25","author":"Thomsen","year":"1999","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.bone.2018.07.026_bb0155","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrendo.2009.58","article-title":"Bone: use of bisphosphonates in children-proceed with caution","volume":"5","author":"Marini","year":"2009","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"10.1016\/j.bone.2018.07.026_bb0160","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/8756-3282(95)00439-4","article-title":"Long-term effects of clodronate on growing rat bone","volume":"18","author":"Lepola","year":"1996","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bone.2018.07.026_bb0165","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S8756-3282(02)00974-2","article-title":"Alendronate affects long bone length and growth plate morphology in the oim mouse model for osteogenesis imperfecta","volume":"32","author":"Evans","year":"2003","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bone.2018.07.026_bb0170","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1210\/en.2013-1993","article-title":"Effect of bisphosphonates on the rapidly growing male murine skeleton","volume":"155","author":"Zhu","year":"2014","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.bone.2018.07.026_bb0175","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.bone.2008.01.001","article-title":"Effects of alendronate and pamidronate on cultured rat metatarsal bones: failure to prevent dexamethasone-induced growth retardation","volume":"42","author":"Heino","year":"2008","journal-title":"Bone"},{"issue":"6984","key":"10.1016\/j.bone.2018.07.026_bb0180","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature02444","article-title":"Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis","volume":"428","author":"Koga","year":"2004","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bone.2018.07.026_bb0185","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1359\/JBMR.0301234","article-title":"The signaling adapter protein DAP12 regulates multinucleation during osteoclast development","volume":"19","author":"Humphrey","year":"2004","journal-title":"J. Bone Miner. Res."},{"issue":"10","key":"10.1016\/j.bone.2018.07.026_bb0190","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1074\/jbc.M113.494542","article-title":"Mechanism and function of monoclonal antibodies targeting siglec-15 for therapeutic inhibition of osteoclastic bone resorption","volume":"289","author":"Stuible","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bone.2018.07.026_bb0195","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/43.5.7730591","article-title":"The septoclast, a cathepsin B-rich cell involved in the resorption of growth plate cartilage","volume":"43","author":"Lee","year":"1995","journal-title":"J. Histochem. Cytochem."},{"issue":"1","key":"10.1016\/j.bone.2018.07.026_bb0200","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1210\/endo.134.1.7506213","article-title":"Reduced chondroclast differentiation results in increased cancellous bone volume in estrogen-treated growing rats","volume":"134","author":"Turner","year":"1994","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.bone.2018.07.026_bb0205","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JOE-13-0276","article-title":"Cartilage to bone transitions in health and disease","volume":"219","author":"Staines","year":"2013","journal-title":"J. Endocrinol."},{"issue":"5","key":"10.1016\/j.bone.2018.07.026_bb0210","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJMoa023110","article-title":"Bisphosphonate-induced osteopetrosis","volume":"349","author":"Whyte","year":"2003","journal-title":"N. Engl. J. Med."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328218302941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328218302941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T04:57:04Z","timestamp":1751777824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328218302941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":42,"alternative-id":["S8756328218302941"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2018.07.026","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Siglec-15-targeting therapy increases bone mass in rats without impairing skeletal growth","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2018.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}